Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
Sarah-Eve LemayCharifa AwadaTsukasa ShimauchiWen-Hui WuSebastien BonnetSteeve ProvencherOlivier BoucheratPublished in: Cells (2021)
Pulmonary arterial hypertension is a debilitating chronic disorder marked by the progressive obliteration of the pre-capillary arterioles. This imposes a pressure overload on the right ventricle (RV) pushing the latter to undergo structural and mechanical adaptations that inexorably culminate in RV failure and death. Thanks to the advances in molecular biology, it has been proposed that some aspects of the RV and pulmonary vascular remodeling processes are orchestrated by a subversion of developmental regulatory mechanisms with an upregulation of a suite of genes responsible for the embryo's early growth and normally repressed in adults. In this review, we present relevant background regarding the close relationship between overactivation of fetal genes and cardiopulmonary remodeling, exploring whether the reawakening of developmental factors plays a causative role or constitutes a protective mechanism in the setting of PAH.
Keyphrases
- pulmonary arterial hypertension
- mycobacterium tuberculosis
- pulmonary hypertension
- pulmonary artery
- genome wide identification
- genome wide
- transcription factor
- genome wide analysis
- multiple sclerosis
- bioinformatics analysis
- dna methylation
- copy number
- poor prognosis
- cell proliferation
- signaling pathway
- coronary artery
- polycyclic aromatic hydrocarbons
- gene expression
- heart failure